Supplemental treatments, such as Ginkgo biloba and a host of other antioxidants, can help address the systemic sources of ocular nerve damage and help to improve blood flow to the eye.
Glaucoma, as one of the leading causes of blindness and currently affecting up to four million Americans, is a general name given to a group of optic neuropathies characterized by the degeneration of the optic nerve, and age, race, family history, and elevated IOP are widely known risk factors for the disease.
While high IOP is currently the only modifiable risk factor, 15% to 30% of persons with ocular hypertension never develop glaucoma pathology, and conversely, patients with acceptable IOP still sustain ocular nerve damage.
Despite significant strides in diagnostic technology and advanced clinical treatment modalities, there are still many questions as to the causal root of glaucoma. Prevalent glaucoma management protocols aim to reduce and control IOP levels but may neglect to address the systemic sources of ocular nerve damage.
Inder Paul Singh, MD
E: [email protected]
Dr. Singh is a glaucoma specialist practicing at The Eye Centers of Racine and Kenosha in Wisconsin. He did not indicate any proprietary interest relevant to the subject matter.